The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus
NCT ID: NCT00363233
Last Updated: 2007-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
80 participants
INTERVENTIONAL
2006-03-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico
NCT06683235
The Effect of Alpha Linolenic Acid Intake on Patients With Elevated Glycemic Status
NCT05053347
Does Flaxseed Supplementation Improve Glycemic Control in Individuals With Pre-diabetes?
NCT01698112
ACUTE EFFECT OF CONSUMPTION OF GROUND OR WHOLE FLAXSEEDS ON BLOOD GLUCOSE IN PEOPLE WITH TYPE 2 DIABETES
NCT06912542
Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes
NCT06911060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
flax lignans
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 50-79 years old
* LDL-cholesterol more than 2.9 mmol/l
Exclusion Criteria
* Cancer
* Chronic gastrointestinal diseases
* Current use of antibiotics
* Any severe liver or renal diseases
* Systolic blood pressure more than 180 mmHg or phase 3 hypertension
* Any severe mental diseases
* Severe cardio- or cerebro-vascular diseases
50 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Academy of Sciences
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xu Lin, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute for Nutritional Sciences, Chinese Academy of Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Nutritional Sciences, Chinese Academy of Sciences; Huadong Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, Wang Y, Gu W, Zhang X, Chen X, Demark-Wahnefried W, Liu Y, Lin X. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One. 2007 Nov 7;2(11):e1148. doi: 10.1371/journal.pone.0001148.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04DZ14007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.